Insmed Incorporated INSM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 268.43% | 296.11% | 229.62% | 152.62% | 52.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 268.43% | 296.11% | 229.62% | 152.62% | 52.36% |
| Cost of Revenue | 166.35% | 139.40% | 122.86% | 69.09% | 38.71% |
| Gross Profit | 294.96% | 351.57% | 261.37% | 180.52% | 56.36% |
| SG&A Expenses | 35.76% | 59.90% | 67.58% | 49.10% | 56.71% |
| Depreciation & Amortization | 228.35% | 64.77% | 64.77% | 53.37% | 21.77% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.18% | 45.81% | 56.90% | 46.87% | 38.17% |
| Operating Income | 68.69% | 60.10% | 12.86% | -1.83% | -31.50% |
| Income Before Tax | 73.51% | 96.45% | 36.60% | -39.55% | -67.97% |
| Income Tax Expenses | 101.97% | 50.36% | 60.64% | 22.51% | 30.18% |
| Earnings from Continuing Operations | 72.89% | 95.88% | 36.25% | -39.46% | -67.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 72.89% | 95.88% | 36.25% | -39.46% | -67.79% |
| EBIT | 68.69% | 60.10% | 12.86% | -1.83% | -31.50% |
| EBITDA | 71.32% | 61.47% | 13.83% | -0.69% | -31.20% |
| EPS Basic | 73.76% | 96.42% | 46.49% | -16.86% | -37.66% |
| Normalized Basic EPS | 66.97% | 62.97% | 26.08% | 13.58% | -5.75% |
| EPS Diluted | 73.71% | 96.42% | 46.48% | -16.89% | -37.80% |
| Normalized Diluted EPS | 66.97% | 62.97% | 26.08% | 13.58% | -5.75% |
| Average Basic Shares Outstanding | 3.32% | 14.82% | 19.14% | 19.34% | 21.90% |
| Average Diluted Shares Outstanding | 3.32% | 14.82% | 19.14% | 19.34% | 21.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |